Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study

The Lancet HIV

Volumn 3, Issue 4, 2016, Pages e175-e182

  Haas, Andreas D ^a   Tenthani, Lyson ^a,b   Msukwa, Malango T ^a,c   Tal, Kali ^a   Jahn, Andreas ^b,d   Gadabu, Oliver J ^c   Spoerri, Adrian ^a   Chimbwandira, Frank ^d   van Oosterhout, Joep J ^e,f   Keiser, Olivia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b International Training   (Malawi)

^c BAOBAB HEALTH TRUST   (Malawi)

^d MINISTRY OF HEALTH   (Malawi)

^e DIGNITAS INTERNATIONAL   (Malawi)

^f UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; FOLLOW UP; HIV INFECTIONS; MALAWI; MATERNAL CHILD HEALTH CARE; ODDS RATIO; PATIENT DROPOUT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BREAST FEEDING; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOST TO FOLLOW-UP; MALAWI; MATERNAL-CHILD HEALTH SERVICES; MEDICATION ADHERENCE; ODDS RATIO; PATIENT DROPOUTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; YOUNG ADULT;

EID: 84959897536     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)00008-4     Document Type: Article

References (28)

1. 1 Schouten, EJ, Jahn, A, Midiani, D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 378 (2011), 282–284.
2. 2 Ministry of Health of Malawi. Clinical management of HIV in children and adults. http://www.emtct-iatt.org/wp-content/uploads/2015/09/Malawi-HIV-Guidelines-2014.pdf, 2014 (accessed Jan 30, 2016).
3. 3 World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. http://apps.who.int/iris/bitstream/10665/85326/1/9789241505734_eng.pdf, 2013 (accessed Jan 30, 2016).
4. 4 Van Lettow, M, Bedell, R, Mayuni, I, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc, 17, 2014, 18994.
5. 5 Chan, AK, Ford, D, Namata, H, et al. The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res, 14, 2014, 352.
6. 6 Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV—Malawi, July 2011–September 2012. MMWR Morb Mortal Wkly Rep 62 (2013), 148–151.
7. 7 Ministry of Health of Malawi. Integrated HIV program report: October–December 2014. https://www.hiv.health.gov.mw/cha_repository/file.php/92/92.pdf, 2014 (accessed Jan 30, 2016).
8. 8 The Kesho Bora Study Group. Maternal HIV-1 disease progression 18–24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial. Clin Infect Dis 55 (2012), 449–460.
9. 9 Hargrove, JW, Humphrey, JH, Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe. AIDS 24 (2010), F11–F14.
10. 10 Minniear, TD, Girde, S, Angira, F, et al. Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding—Kenya, 2003–2009. PLoS One, 9, 2014, e93556.
11. 11 The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373 (2015), 795–807.
12. 12 Cohen, MS, Chen, YQ, McCauley, M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 (2011), 493–505.
13. 13 ICW, GNP+. Understanding the perspectives and/or experiences of women living with HIV regarding Option B+ in Uganda and Malawi. http://www.gnpplus.net/assets/2013-Option-B+-Report-GNP-and-ICW.pdf, 2013 (accessed Jan 30, 2016).
14. 14 Ngarina, M, Tarimo, EA, Naburi, H, et al. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania. PLoS One, 9, 2014, e85310.
15. 15 Tenthani, L, Haas, AD, Tweya, H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. AIDS 28 (2014), 589–598.
16. 16 Douglas, GP, Gadabu, OJ, Joukes, S, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med, 7, 2010, e1000319.
17. 17 Johnson, LF, Estill, J, Keiser, O, et al. Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?. Am J Epidemiol 180 (2014), 1208–1212.
18. 18 Chi, BH, Yiannoutsos, CT, Westfall, AO, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med, 8, 2011, e1001111.
19. 19 Gooley, TA, Leisenring, W, Crowley, J, Storer, BE, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999), 695–706.
20. 20 Fine, JP, Gray, RJ, A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
21. 21 Wilkinson, LS, Skordis-Worrall, J, Ajose, O, Ford, N, Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis. Trop Med Int Heal 20 (2015), 365–379.
22. 22 Tweya, H, Gugsa, S, Hosseinipour, M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health 19 (2014), 1360–1366.
23. 23 Koole, O, Houben, RM, Mzembe, T, et al. Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005–2012. J Acquir Immune Defic Syndr 67 (2014), 2005–2012.
24. 24 Clouse, K, Schwartz, S, Van Rie, A, Bassett, J, Yende, N, Pettifor, A, “What they wanted was to give birth; nothing else”: barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr 67 (2014), e12–e18.
25. 25 NSO, ICF Macro. Malawi demographic and health survey 2010, 2011, National Statistical Office and ICF Macro, Zomba, Malawi and Calverton, MD, USA.
26. 26 Tenthani, L, Haas, AD, Egger, M, et al. Brief report: HIV testing among pregnant women who attend antenatal care in Malawi. J Acquir Immune Defic Syndr 69 (2015), 610–614.
27. 27 Kim, MH, Ahmed, S, Hosseinipour, MC, et al. Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr 68 (2015), e77–e83.
28. 28 TEMPRANO ANRS 12136 Study Group, Danel, C, Moh, R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 373 (2015), 808–822.